"Learn how the IU Health Neuroscience Center in downtown Indianapolis provides full neurological services in a single location so you get the best for your care."

During the past decade, Indiana University Health Neuroscience Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University Health Neuroscience Center" #1 sponsor was "Pfizer" with 3 trials, followed by "Amicus Therapeutics" with 2 trials sponsored, "Athira Pharma" with 2 trials sponsored, "Alector Inc." with 1 trials sponsored and "Amin B Kassam" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University Health Neuroscience Center" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University Health Neuroscience Center" are "Alzheimer Disease" (2 trials), "Huntington's Disease" (2 trials), "Parkinson Disease" (2 trials), "Pompe Disease (Late-onset)" (2 trials) and "Adolescent" (1 trials). Many other conditions were trialed in "Indiana University Health Neuroscience Center" in a lesser frequency.

Most popular intervention types in "Indiana University Health Neuroscience Center" are "Drug" (14 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AT2221" (2 trials), "ATB200" (2 trials), "ATH-1017" (2 trials) and "20 mg BID of PF-02545920" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University Health Neuroscience Center" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Indiana University Health Neuroscience Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Indiana University Health Neuroscience Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University Health Neuroscience Center, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".